Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW870086X inhaled therapy for allergen-induced early and late asthmatic response in mild asthma
2007-005791-14Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GW870086 in asthma (3 arms), sponsored by GSK. Primary endpoint: Late Asthmatic Response (LAR). Started Nov 2008; status: completed.
02
Drugs
GW870086
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-005791-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005791-14.